GleamWall
中文EN

FUNI Hypha Labs, Inc.

Services-Testing Laboratories · OTC · SEC CIK 1502966 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY36.7%
TTM EPS YoY66.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-729.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets4,618.5%
Debt / equity—
Current ratio0.01x
Interest coverage-4.40x

Cash quality & payout

Operating cash flow / net income0.30x
Accruals ratio-512.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30
Income statement
Revenue——
SG&A expense$1.42M$943,691
Operating income-$3.00M-$1.83M
Interest expense$106,143$201,769
Pretax income-$3.10M-$1.36M
Income tax—$14,189
Net income-$3.10M-$785,429
EBITDA-$2.99M-$1.83M
EPS (basic)-0.02-0.01
EPS (diluted)-0.02-0.01
Weighted avg. shares (diluted)135.15M101.35M
Balance sheet
Cash & equivalents$38,118$91,166
Current assets$320,531$410,190
PP&E, net$62,507$26,609
Total assets$409,218$493,805
Current liabilities$1.12M$1.39M
Total liabilities$2.51M$1.42M
Shareholders' equity-$2.44M-$1.26M
Shares outstanding147.12M123.05M
Cash flow statement
Operating cash flow-$379,975-$1.03M
Capital expenditure$32,966$27,655
Free cash flow-$412,941-$1.06M
Investing cash flow-$32,966$2.15M
Financing cash flow$359,893-$1.29M
Depreciation & amortization$10,818$1,046
Stock-based compensation$1.85M$733,748

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.